Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
about
Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectivesAssociation between NQO1 C609T polymorphism and prostate cancer riskARID1A gene silencing reduces the sensitivity of ovarian clear cell carcinoma to cisplatinUpdate on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.X-chromosome-linked inhibitor of apoptosis as a key factor for chemoresistance in clear cell carcinoma of the ovary.Eribulin mesylate targets human telomerase reverse transcriptase in ovarian cancer cells.Lack of association between MTHFD1 G401A polymorphism and ovarian cancer susceptibility.High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers.Prediction of resistance to chemotherapy in ovarian cancer: a systematic review.Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach.Magnetic Resonance Imaging Characteristics of Ovarian Clear Cell Carcinoma.Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials.Two cases of clear cell ovarian cancer in young patients.Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423.Clear cell carcinoma of ovary and uterus.Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinum.Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma.Challenges and Opportunities in Studying the Epidemiology of Ovarian Cancer Subtypes.Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma.Association between estrogen receptor alpha PvuII polymorphism and prostate cancer risk.JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.Subcellular localization of MCM2 correlates with the prognosis of ovarian clear cell carcinoma.
P2860
Q26775315-CA312F1B-AFF9-4DEC-8625-74B8C8EF1D84Q28240340-D95A4602-7D5F-4CE2-A90F-746E25A223D1Q28468340-68A2D4D3-BBDC-48CC-BB8D-1CF0FAE293F0Q33735170-3316C052-40D4-422F-989C-5DB4068ADAE9Q33750177-2DB6B48D-973D-4258-A670-B5CEB9972DFAQ34466428-D1C82110-9399-4951-BD03-1467C1894E48Q35056269-DC5227C7-14A0-49CD-B5AB-9AF301E61C6BQ35098369-55F15935-848C-4999-AA7C-BA86B1776185Q35212386-5901FE86-A069-4253-8892-DFFD43B878D5Q35612005-5BA74755-490F-452E-A917-92F809C64353Q35687723-20162641-34E0-4E69-8064-4CF47FFF96FFQ36826591-3E83D57B-E18F-4136-A343-61BDB18BC3E3Q37335723-5A160483-A969-47BA-9386-AEACA5DAAD92Q37554263-F6FFEE9B-F962-4062-8101-E6EC97760659Q38151508-E0683AC7-8B56-4C4A-9A27-832114149D64Q40009120-D403256C-15AB-478A-8D51-C455AB709554Q42700308-6587EC16-2F72-4081-A6A4-E290D2D01F7AQ45933729-4AE5095B-9AF9-4618-A133-2F30FFE4FC2EQ48107285-C07A9C25-F69E-4008-9BF3-701AAC44B867Q53134069-CEF8C360-7B84-4274-90CF-56CA0517D7BEQ55269538-3421040A-CE1A-4B16-B735-7FCD76D6AD18Q55363680-84C361BA-3218-41EC-B77D-424AFFB38AD1
P2860
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
@ast
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
@en
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
@nl
type
label
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
@ast
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
@en
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
@nl
prefLabel
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
@ast
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
@en
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
@nl
P2093
P2860
P921
P356
P1476
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
@en
P2093
Hiroshi Tsuda
Masashi Takano
Toru Sugiyama
P2860
P2888
P356
10.1186/1756-9966-31-53
P407
P5008
P577
2012-06-01T00:00:00Z
P5875
P6179
1019656520